It is everywhere, and it is extremely dangerous for people with a weakened immune system. The fungus Aspergillus fumigatus occurs virtually everywhere on Earth, as a dark grey, wrinkled cushion on damp walls or in microscopically small spores that blow through the air and cling to wallpaper, mattresses and floors. Healthy people usually have no problem if spores find their way into their body, as their immune defense system will put the spores out of action. However, the fungus can threaten the lives of people with a compromised immune system, such as AIDS patients or people who are immunosuppressed following an organ transplantation.
An international research team led by professor Oliver Werz of Friedrich Schiller University, Jena, has now discovered how the fungus knocks out the immune defences, enabling a potentially fatal fungal infection to develop. The researchers present their findings in the current issue of the specialist journal Cell Chemical Biology.
Among other factors, it is gliotoxin -- a potent mycotoxin -- that is responsible for the pathogenicity of Aspergillus fumigatus.
"It was known that this substance has an immunosuppressive effect, which means that it weakens the activity of cells of the immune defense system," says Werz. "However, it had not been clear previously how exactly this happens."
Werz and his team colleagues have now studied this in detail and have clarified the underlying molecular mechanisms. To achieve this, the researchers brought immune cells into contact with synthetically produced gliotoxin. These cells, called neutrophilic granulocytes, represent the first line of the immune defence system. "Their task is to detect pathogens and eliminate them," explains Werz. As soon as such a cell comes into contact with a pathogen, for example a fungus, it releases specific messenger substances (leukotrienes) into the blood, which attract other immune cells. Once a sufficiently large number of immune cells has gathered, they can render the intruder harmless.
This does not happen if the pathogen Aspergillus fumigatus is involved. As the scientists were able to show, gliotoxin ensures that production of the messenger substance leukotrieneB4 in the neutrophilic granulocytes is inhibited, so that they are unable to send a signal to other immune cells. This is caused by a specific enzyme (LTA4 hydrolase) being switched off by the mycotoxin.
"This interrupts communication between the immune cells and destroys the defense mechanism. As a result, it is easy for spores -- in this case the fungus -- that enter the organism to infiltrate tissues or organs," says Werz.
For their study, Werz and his colleagues collaborated with researchers from the Leibniz Institute for Natural Product Research and Infection Biology (Hans Knöll Institute). As part of the Collaborative Research Centre ChemBioSys and the Jena Cluster of Excellence 'Balance of the Microverse', they cooperated with the working groups led by professor Axel Brakhage and professor Christian Hertweck, which contributed their expertise in mycology and natural product synthesis. Additional partners are research groups from the Universities of Frankfurt and Naples, as well as the Karolinska Institute in Stockholm.
Reference: Koenig S et al. Gliotoxin from Aspergillus fumigatus Abrogates Leukotriene B4 Formation through Inhibition of Leukotriene A4 Hydrolase, Cell Chemical Biology 26, 1-11 (2019), DOI: 10.1016/j.chembiol.2019.01.001, https://www.cell.com/cell-chemical-biology/fulltext/S2451-9456(19)30001-7
APIC Salutes 2025 Trailblazers in Infection Prevention and Control
June 18th 2025From a lifelong mentor to a rising star, the Association for Professionals in Infection Control and Epidemiology (APIC) honored leaders across the career spectrum at its 2025 Annual Conference in Phoenix, recognizing individuals who enhance patient safety through research, leadership, and daily practice.
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge
June 17th 2025When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.